Asthma, bronchiectasis, and chronic obstructive pulmonary disease: the Bermuda Triangle of the airways.
作者信息
Martínez García Miguel Ángel, Soriano Joan B
机构信息
Pneumology Department, Hospital Universitario y Politécnico la Fe de Valencia, Spain.
CIBERES de enfermedades respiratorias, Instituto de salud Carlos III, Madrid, Spain.
出版信息
Chin Med J (Engl). 2022 Jun 20;135(12):1390-1393. doi: 10.1097/CM9.0000000000002225.
Abstract
摘要
相似文献
1
Asthma, bronchiectasis, and chronic obstructive pulmonary disease: the Bermuda Triangle of the airways.哮喘、支气管扩张症和慢性阻塞性肺疾病：气道的百慕大三角。
Chin Med J (Engl). 2022 Jun 20;135(12):1390-1393. doi: 10.1097/CM9.0000000000002225.
2
Long-term efficiency of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease, bronchiectasis, and asthma: Does it differ?慢性阻塞性肺疾病、支气管扩张和哮喘患者肺康复的长期疗效：是否存在差异？
Turk J Med Sci. 2023 Jun;53(3):814-823. doi: 10.55730/1300-0144.5644. Epub 2023 Jun 19.
3
Clinical year in review II: occupational lung disease, pulmonary vascular disease, bronchiectasis, and chronic obstructive pulmonary disease.年度临床回顾II：职业性肺病、肺血管疾病、支气管扩张症及慢性阻塞性肺疾病
Proc Am Thorac Soc. 2006 Sep;3(7):557-60. doi: 10.1513/pats.200606-135TT.
4
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial.靶向抗生素治疗慢性肺部疾病（TARGET ABC）：靶向抗生素治疗能否改善慢性阻塞性肺疾病、非囊性纤维化支气管扩张症和哮喘合并铜绿假单胞菌感染患者的预后？一项多中心、随机、对照、开放标签试验。
Trials. 2022 Sep 27;23(1):817. doi: 10.1186/s13063-022-06720-z.
5
The 'ABC' of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians - a systematic review.成人原住民呼吸障碍的“ABC”：澳大利亚原住民的哮喘、支气管扩张症和 COPD - 系统评价。
BMJ Open Respir Res. 2023 Jul;10(1). doi: 10.1136/bmjresp-2023-001738.
6
Airway disease in alpha-1 antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中的气道疾病。
COPD. 2013 Mar;10 Suppl 1:68-73. doi: 10.3109/15412555.2013.764404.
7
Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.体力活动与严重哮喘、支气管扩张和 COPD 的疾病特征有关。
Respirology. 2019 Apr;24(4):352-360. doi: 10.1111/resp.13428. Epub 2018 Nov 1.
8
Bronchiectasis phenotypes.支气管扩张症表型。
Curr Opin Pulm Med. 2019 May;25(3):281-288. doi: 10.1097/MCP.0000000000000569.
9
Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021.2008 年至 2021 年期间英格兰四种主要慢性呼吸道疾病的患者路径。
BMJ Open Respir Res. 2024 Aug 28;11(1):e002273. doi: 10.1136/bmjresp-2023-002273.
10
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.土耳其慢性阻塞性肺疾病、支气管扩张或哮喘患者的α-1 抗胰蛋白酶缺乏症筛查研究。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 28;18:2785-2794. doi: 10.2147/COPD.S425835. eCollection 2023.
本文引用的文献
1
[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.[翻译文章] 《西班牙哮喘管理指南》（GEMA）第5.1版。要点与争议。
Arch Bronconeumol. 2022 Feb;58(2):T150-T158. doi: 10.1016/j.arbres.2021.05.032. Epub 2022 Feb 14.
2
Bronchiectasis and Eosinophils.支气管扩张症与嗜酸性粒细胞
Arch Bronconeumol. 2021 Nov;57(11):671-672. doi: 10.1016/j.arbr.2021.08.001.
3
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.《2021年全球哮喘防治创议策略》。执行摘要及关键变化的理论依据。
Arch Bronconeumol. 2022 Jan;58(1):35-51. doi: 10.1016/j.arbres.2021.10.003. Epub 2021 Oct 28.
4
Eosinophils and eosinophilic immune dysfunction in health and disease.在健康和疾病中嗜酸性粒细胞和嗜酸性免疫功能障碍。
Eur Respir Rev. 2022 Jan 25;31(163). doi: 10.1183/16000617.0150-2021. Print 2022 Mar 31.
5
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations.支气管扩张症在成人中的放射学和临床诊断标准及定义：用于临床试验的国际共识建议。
Lancet Respir Med. 2022 Mar;10(3):298-306. doi: 10.1016/S2213-2600(21)00277-0. Epub 2021 Sep 24.
6
Association between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study.中国江苏省社会经济地位与慢性阻塞性肺疾病的关系：一项基于人群的研究。
Chin Med J (Engl). 2021 Jun 22;134(13):1552-1560. doi: 10.1097/CM9.0000000000001609.
7
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.美泊利珠单抗治疗伴有支扩的严重嗜酸性粒细胞性哮喘患者的有效性：一项真实世界回顾性研究。
Respir Med. 2021 Aug-Sep;185:106491. doi: 10.1016/j.rmed.2021.106491. Epub 2021 Jun 1.
8
Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat.哮喘治疗中的生物制剂：别让“神奇子弹”翻了船。
Arch Bronconeumol (Engl Ed). 2021 Jun;57(6):383-384. doi: 10.1016/j.arbr.2021.04.004. Epub 2021 Apr 15.
9
The Roles of Bacteria and Viruses in Bronchiectasis Exacerbation: A Prospective Study.细菌和病毒在支气管扩张症恶化中的作用：一项前瞻性研究。
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):621-629. doi: 10.1016/j.arbr.2019.12.014. Epub 2020 Oct 1.
10
Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD.《2021年西班牙慢性阻塞性肺疾病指南（GesEPOC）：稳定期慢性阻塞性肺疾病的药物治疗更新》
Arch Bronconeumol. 2022 Jan;58(1):69-81. doi: 10.1016/j.arbres.2021.03.005. Epub 2021 Mar 17.
Zotero 插件